FDA Adverse Event Injury Summary report: N

INRATIO

MDR report key: 2850050 · Received November 26, 2012

Report

Report Number
2027969-2012-01632
Event Type
Injury
Date Received
November 26, 2012
Date of Event
November 5, 2012
Report Date
November 26, 2012
Manufacturer
ALERE SAN DIEGO, INC
Product Code
GJS
PMA / PMN Number
K021923
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION PENDING.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH ANOTHER LOT. RESULTS AS FOLLOWS: DATE: (B)(6) 2012, INRATIO: 2.8, LOT: 284364. DATE: (B)(6) 2012, INRATIO: 5.0, LOT: 291547. TIME BETWEEN TESTING WAS LESS THAN 30 MINUTES. PATIENT'S THERAPEUTIC RANGE IS 2.5 - 3.5. IT WAS REPORTED THE PATIENT NOTICED BRUISING. THE PATIENT HAD A LAB COMPARISON PERFORMED THE NEXT DAY. RESULTS AS FOLLOWS. DATE: (B)(6) 2012, INRATIO: 5.0, LAB: 4.8, LOT NUMBER NOT PROVIDED. THERE WAS NO ADVERSE PATIENT SEQUELA. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC 100071 284364

Patients

Seq Age Sex Outcome Treatment
1 Other 1.5 WEEKS PRIOR| COUMADIN, B12| DOXYCYCLINE-STOPPED TREATMENT APPROX.